← Leaderboards
Sara Albert
Leidos Biomedical Research, Inc.
$9,235,930
Attributed
$9,235,930
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.5M · FY2019–24$10M$7.5M$5M$2.5M$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,235,930 · 1
By mechanism
N01$9,235,930 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Ethan Dmitrovsky$597,515,186
- William Bocik$34,535,363
- Beth Baseler$335,223,481
Others in their field
Other Emerging Leaders on “Programs”
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$348,328,584
- Lynn Briscoe · Leidos Biomedical Research, Inc.$312,382,073
- Chanza Baytop · Westat, Inc.$271,217,917
Research focus
ProgramsAfricaCardiovascular DiseasesChronic DiseaseClinical ResearchCo-InfectionDisease ProgressionEpidemiologyHiv InfectionsKidney DiseasesTreatment ResponseResponseAcceleration